Skip to main content

Advertisement

SpringerLink
Log in

Differences in prevalence of diabetes mellitus type 2 and impaired fasting glucose between urban and rural areas according to PURE Poland substudy

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

This paper presents baseline results of the Prospective Urban Rural Epidemiology (PURE) Poland substudy of differences in prevalence of diabetes and impaired fasting glucose (IFG) between urban and rural areas. It covers group of 1643 people, aged 35 to 70 years old, inhabitants of Lower Silesia. The PURE study reached 22 countries with different statuses of economic development. All participants were tested in accordance to PURE project protocol. Data was collected at family (household) level and individual level. Diabetes was found in 12.0 % of our study population, IFG in 28.1 %, and normal glucose level in 59.9 %. Diabetes and IFG were more common in rural than in urban population, and higher percentage of people with diabetes was found in men comparing to women. In the PWBEC study conducted in years 1998–2000, diabetes prevalence was 5.3 %, in the NATPOL study conducted in years 1997–2002, 5.6 %; and in the latest PONS study from Świętokrzyskie voivodeship, 8.4 %. The percentage of people with diabetes in PURE Poland substudy was as high as 12 % and was higher than projections of diabetes prevalence in Poland for year 2030 (11.6 %). Significant differences of diabetes and IFG prevalence in respect to education and place of residence may arise from different attitudes of groups of patients to many other factors connected with prevention, treatment, and rehabilitation. Our study will continue to disclose other relevant risk factors in chosen areas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bolduan CF. Diabetes—an important public health problem. Am J Public Health Nations Health. 1938;28(1):21–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35(Suppl 1):S64–71. doi:10.2337/dc12-s064.

    Article  Google Scholar 

  3. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14. doi:10.1016/j.diabres.2009.10.007.

    Article  CAS  PubMed  Google Scholar 

  4. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782–7.

    Article  CAS  PubMed  Google Scholar 

  5. Boyle J, Honeycutt A, Narayan K. Projection of diabetes burden through 2050. Diabetes Care. 2001;24(11):1936–40. doi:10.2337/diacare.24.11.1936.

    Article  CAS  PubMed  Google Scholar 

  6. Simmons RK, Unwin N, Griffin SJ. International diabetes federation: an update of the evidence concerning the prevention of type 2 diabetes. IDF Diabetes Atlas (4th ed.). Diabetes Res Clin Pract. 2010;87(2):143–9. doi:10.1016/j.diabres.2009.10.003.

    Article  CAS  PubMed  Google Scholar 

  7. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:–2569. doi:10.2337/diacare.27.10.2569.

  8. IDF DIABETES ATLAS fifth edition [article online]. Available from http://www.idf.org/diabetesatlas/5e/foreword (2012). Accessed 25 Oct 2012.

  9. Diabetes [article online]. http://www.who.int/mediacentre/factsheets/fs312/en/ (2012). Accessed 25 Oct 2012.

  10. Tsigos C, Hainer V, Basdevent A, Finer N, Fried M, Mathus-Vliegen E, et al. Management of obesity in adults: European clinical practice guidelines. Obes Facts. 2008;1(2):106–16. doi:10.1159/000126822.

    Article  PubMed  Google Scholar 

  11. Shafrir E. Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia. Diabetes Metab. 1997;22:131–48.

    Google Scholar 

  12. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care. 1998;21(7):1138–45.

    Article  CAS  PubMed  Google Scholar 

  13. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 1999;48(5):937–42.

    Article  CAS  PubMed  Google Scholar 

  14. Zatoński W. In: Mańczuk M, Sulkowska U, The HEM Project team, editors. Closing the health gap in European Union. Cancer Center and Institute of Oncology, Warsaw (2008). Available from http://www.hem.waw.pl/?idm=87,139&cmd=1. Accessed 05 Sep 2016.

  15. Grzeszczak W. Ryzyko rozwoju cukrzycy oraz jej powikłań–co nowego opublikowano na ten temat na początku 2011 roku? Choroby Serca i Naczyń. 2011;8(3):132–8.

    Google Scholar 

  16. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, et al. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 2005;92(11):2076–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Czyżyk A, Szczepanik Z. Diabetes mellitus and cancer. Eur J Intern Med. 2000;11:245–52.

    Article  PubMed  Google Scholar 

  18. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005;97(22):1679–87.

    Article  PubMed  Google Scholar 

  19. El–Seraq HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006;4(3):369–80.

    Article  Google Scholar 

  20. Larsson SC, Orsini N, Brismar K, Wolk A. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia. 2006;49(12):2819–23.

    Article  CAS  PubMed  Google Scholar 

  21. Kasper JS., Giovanucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomark Prev 2006;15(11):2056–2062.

  22. Friberg E, Orsini N, Mantzoros CS, Wolak A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007;50:1365–74.

    Article  CAS  PubMed  Google Scholar 

  23. Lindblad P, Chow WH, Chan J, et al. The role of diabetes mellitus in the etiology of renal cell cancer. Diabetologia. 1999;42(1):107–12.

    Article  CAS  PubMed  Google Scholar 

  24. Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007;121(4):856–62.

    Article  CAS  PubMed  Google Scholar 

  25. Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr. 2007;86(3):823–35.

    Google Scholar 

  26. Nowakowski A. Epidemiologia cukrzycy. Diabetol Prakt. 2002;3:181–5.

    Google Scholar 

  27. Sieradzki J. Cukrzyca. Gdańsk: Wydawnictwo Via Medica; 2006.

    Google Scholar 

  28. Sulicka J, Fornal M, Gryglewska B, Wizner B, Grodzicki T. Selected cardiovascular risk factors in primary care patients. Arterial Hypertension. 2006;10:370–6.

    Google Scholar 

  29. Kawalec P, Kielar M, Pilc A. Koszty leczenia cukrzycy typu 1 i 2 w Polsce. Diabetologia Praktyczna. 2006;7(5):287–94.

    Google Scholar 

  30. Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, Nichols G. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(3):293–301. doi:10.1016/j.diabres.2010.01.026.

    Article  PubMed  Google Scholar 

  31. Teo K, Chow CK, Vaz M, Rangarajan S. Yusuf S; PURE Investigators-Writing Group. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J. 2009;158(1):1–7. doi:10.1016/j.ahj.2009.04.019.

    Article  PubMed  Google Scholar 

  32. Szybiński Z. Polskie Wieloośrodkowe Badania nad Epidemiologią Cukrzycy (PWBEC)-1998-2000. Pol Arch Med Wewn. 2001;3:751–91.

    Google Scholar 

  33. Zdrojewski T, Bandosz P, Szpakowski P, et al. Ocena wybranych problemów dotyczących wybranych terapii nadciśnienia tętniczego w Polsce na podstawie badania NATPOL III PLUS. In: Więcek A, Kokot F, editors. Postępy w nefrologii i nadciśnieniu tętniczym. T. II. Krąków: Medycyna Prakt; 2003. p. 11–5.

    Google Scholar 

  34. Zatońska K, Ilow R, Regulska-Ilow B, Różańska D, Szuba A, Wołyniec M, Einhorn J, Vatten L, Asvold BC, Mańczuk M, Zatoński WA. Prevalence of diabetes mellitus and IFG in the prospective cohort ’PONS’ study—baseline assessment. Ann Agric Environ Med. 2011;18(2):265–9.

    PubMed  Google Scholar 

  35. Korzeniowska K, Jabłecka A. Cukrzyca (część I). Farmacja wspołczesna. 2008;1:231–5.

    Google Scholar 

  36. Bandurska-Stankiewicz B, Myszka-Podgórska K, Cylkowska B, Surdykowski L, Moczulska B. Częstość występowania cukrzycy nieznanej i stanów przed cukrzycowych w populacji województwa warmińsko-mazurskiego. Przegląd Kardiologiczny. 2007;2(1):41–7.

    Google Scholar 

  37. Gillam S, Yates J, Badrinath P. Essential public health, Cambridge; 2007;78–79.

  38. Czupryniak L. Nowe trendy w Diabetologii 2012/2013. Poznań: Temida; 2012. p. 15–6.

    Google Scholar 

  39. Lear SA, Teo K, et al., on behalf of the Prospective Urban Rural Epidemiology (PURE) study. The association between ownership of common household devices and obesity and diabetes in high, middle and low income countries. CMAJ. 186(4):258–66. doi:10.1503/cmaj.131090.

Download references

Acknowledgments

Polish PURE sub-study is co-funded by Polish Ministry and Science and Higher Education (grant no.290/W-PURE/2008/0) and Wrocław Medical University. The main PURE study and its components are funded by Population Health Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario and through unrestricted grants from several pharmaceutical companies [39].

Author information

Authors and Affiliations

  1. Department of Social Medicine, Wrocław Medical University, ul. Bujwida 44, 50-345, Wrocław, Poland

    Katarzyna Zatońska, Katarzyna Połtyn-Zaradna, Jakub Einhorn, Maria Wołyniec & Dagmara Gaweł-Dąbrowska

  2. Division of Angiology, Wrocław Medical University, ul. Bartla 5, 51-618, Wrocław, Poland

    Andrzej Szuba

  3. Department of Internal Medicine, 4th Military Hospital in Wrocław, ul. Weigla 5, 50-981, Wrocław, Poland

    Andrzej Szuba

  4. Division of Epidemiology and Cancer Prevention, Maria Skłodowska-Curie Memorial Cancer Center & Institute of Oncology, ul. Roentgena 5, 02-781, Warsaw, Poland

    Witold Zatoński

Authors
  1. Katarzyna Zatońska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katarzyna Połtyn-Zaradna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jakub Einhorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Wołyniec
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dagmara Gaweł-Dąbrowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Andrzej Szuba
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Witold Zatoński
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jakub Einhorn.

Ethics declarations

Informed consent was obtained from all individual participants included in the study. All human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki.

Author contributions

Katarzyna Zatońska wrote the manuscript, researched data, contributed to discussion, and reviewed manuscript.

Katarzyna Połtyn-Zaradna wrote the manuscript, contributed to discussion, and reviewed the manuscript.

Jakub Einhorn wrote the manuscript, contributed to the discussion, edited, and reviewed the manuscript.

Maria Wołyniec collected and researched data.

Dagmara Gaweł-Dąbrowska wrote the manuscript and contributed to discussion.

Andrzej Szuba researched the data and reviewed the manuscript.

Witold Zatoński is the article guarantor.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zatońska, K., Połtyn-Zaradna, K., Einhorn, J. et al. Differences in prevalence of diabetes mellitus type 2 and impaired fasting glucose between urban and rural areas according to PURE Poland substudy. Int J Diabetes Dev Ctries 37, 305–312 (2017). https://doi.org/10.1007/s13410-016-0523-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-016-0523-4

Keywords

Search

Navigation